Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deals Of The Week: Merck/Chimerix, Merck/Yamasa, CoDa/Rusnano/Domain

Jul 30 2012

• By Paul Bonanos, Wendy Diller, Michael Goodman, and Jessica Merrill

Related Content

In A Changing Diabetes Drug Market, Who Will Come Out On Top?

Jul 16 2012

Chimerix Chooses Merck As HIV Partner, Keeps Broad-Spectrum Antiviral

Jul 24 2012

CoDa Therapeutics Closes B Round with $40 Million from Rusnano/ Domain-Led Syndicate

Jul 24 2012

Brennan’s Abrupt Departure Has Some Viewing AstraZeneca As A Buyout Target

Apr 26 2012

Related Companies

AstraZeneca PLC

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Ardea Biosciences, Inc.

Cellworks Group Inc.

Link Medicine Corporation

Axerion Therapeutics Inc.

Amgen, Inc.

The Medicines Company

Merck & Co., Inc.

Chimerix, Inc.

Yamasa Corporation

CoDa Therapeutics Inc.

NovaMedica LLC

Boehringer Ingelheim GmbH

Funxional Therapeutics Ltd.

Roche Holding AG

Additional Topics

Deals BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window